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Abstract
Background—Trends in state-level prevalence of pre-pregnancy diabetes mellitus (PDM; i.e., 
type 1 or type 2 diabetes diagnosed before pregnancy) among delivery hospitalizations are needed 
to inform healthcare delivery planning and prevention programs.
Purpose—To examine PDM trends overall, by age group, race/ethnicity, primary payer, and 
with comorbidities such as pre-eclampsia and pre-pregnancy hypertension, and to report changes 
in prevalence over 11 years.
Methods—In 2014, State Inpatient Databases from the Agency for Healthcare Research and 
Quality were analyzed to identify deliveries with PDM and comorbidities using diagnosis-related 
group codes and ICD-9-CM codes. General linear regression with a log-link and binomial 
distribution was used to assess the annual change.
Results—Between 2000 and 2010, PDM deliveries increased significantly in all age groups, all 
race/ethnicity groups, and in all states examined (p<0.01). The age-standardized prevalence of 
PDM increased from 0.65 per 100 deliveries in 2000 to 0.89 per 100 deliveries in 2010, with a 
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relative change of 37% (p<0.01). Although PDM rates were highest in the South, some of the 
largest relative increases occurred in five Western states (≥9%). Non-Hispanic blacks had the 
highest PDM rates and the highest absolute increase (0.26 per 100 deliveries). From 2000 to 2010, 
the proportion of PDM deliveries with pre-pregnancy hypertension increased significantly 
(p<0.01) from 7.4% to 14.1%.
Conclusions—PDM deliveries are increasing overall and particularly among those with PDM 
who have hypertension. Effective diabetes prevention and control strategies for women of 
childbearing age may help protect their health and that of their newborns.
Introduction
From 1988–1994 to 2005–2010, the prevalence of diabetes in the U.S. increased 
significantly among young adults (aged 20–34 years).1 In addition, projections of diabetes 
prevalence among those aged <20 years indicate that, if the incidence continues to increase 
as it has over recent years, the number with type 1 diabetes will triple and the number with 
type 2 diabetes will quadruple by 2050.2 An increasing burden of disease among younger 
age groups places more women at risk of diabetes prior to pregnancy. Women diagnosed 
with pre-pregnancy type 1 or type 2 diabetes mellitus (PDM) could experience numerous 
adverse health outcomes if diabetes is poorly controlled during pregnancy.3 Yet, only 40%–
60% of women with PDM achieve glycemic control prior to and early in pregnancy.4–6 
Additionally, a large growth in the prevalence of diabetes and hypertension comorbidity 
among adults aged 20–44 years has been reported in the 2000s.7 To our knowledge, no 
recent state-level estimates of the prevalence of PDM in pregnancy are available. Because 
there are many complications associated with PDM for both the mother and child, it is 
crucial to monitor the prevalence of PDM to inform healthcare delivery planning and the 
identification and implementation of prevention programs. For U.S. states with available 
data, PDM trends from 2000 to 2010 by race/ethnicity, type of insurance, and associated 
comorbidities, such as pre-eclampsia and pre-pregnancy hypertension were assessed.
Methods
Data Source
Data from the Agency for Healthcare Research and Quality (AHRQ) State Inpatient 
Databases (SID) was used to identify maternal hospital discharges involving PDM. SID 
contains information on hospital inpatient stays for states that volunteer to participate in the 
Healthcare Cost and Utilization Project (HCUP). Annual data collection of SID includes all 
community hospitals from the participating states: Arizona, California, Colorado, Florida, 
Hawaii, Iowa, Kentucky, Maryland, Massachusetts, Michigan, New Jersey, New York, 
North Carolina, Oregon, South Carolina, Utah, Washington, West Virginia, and Wisconsin. 
Community hospitals are defined as short-term, non-federal, general and other hospitals, 
public and privately owned excluding hospital units of other institutions (e.g., prisons), and 
long-term rehabilitation centers.8 Community hospitals (and HCUP data) include obstetrics 
and gynecology, ear, nose, and throat, orthopedic, cancer, pediatric, public, and academic 
medical hospitals. Some states exclude hospitals with a main focus on long-term care, 
psychiatric, and alcoholism and chemical dependency treatment, although discharges from 
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these types of units that are part of community hospitals are included. Although not all states 
include such hospitals, the numbers of deliveries from these types of hospitals are minimal 
and therefore any differences in the population of deliveries would be minimal. Further, the 
study population is largely a census of community hospitals, not a sample. Together, SID 
encompasses 97% of all U.S. community hospital discharges.8 AHRQ receives discharge 
data from the states and provide them in a uniform format so that multistate comparisons 
may be made.
Measures and Definitions
Hospital delivery discharges were identified using Diagnosis-Related Group (DRG) codes. 
DRGs comprise a patient classification system that categorizes hospital stays into groups 
that are clinically homogeneous with respect to resource use, including diagnosis and type of 
treatment/procedure. Each hospital stay has one DRG assigned to it. Delivery stays were 
identified by discharges having a DRG code of 767–768 and 774–775 (vaginal delivery) or 
765–7766 (C-section) from October 2007 through December 2010 or a DRG code 372–375 
(vaginal delivery) or 370–371 (C-section) from January 2000 through September 2007 listed 
anywhere on the discharge record.
Hospital delivery discharges with PDM were identified by the presence of an ICD-9-CM 
code of 648.0x (i.e., diabetes mellitus, pre-pregnancy), 250.xx (i.e., diabetes mellitus), or 
249.xx (i.e., secondary diabetes) listed anywhere on the discharge record. Gestational 
diabetes is not included in any of these ICD codes.
Examined variables included maternal age at time of discharge, race/ethnicity, and primary 
insurance payer (e.g., private, Medicare/Medicaid, other government insurance including 
Worker's Compensation, Civilian Health and Medical Program of the Uniformed Services, 
Civilian Health and Medical Program of the Department of Veterans Affairs, Title V, other 
government programs, or uninsured). Medicare and Medicaid were combined, although 
deliveries expected to be funded by Medicare were only about 1% (e.g., nonretirees) of the 
total. PDM deliveries complicated by hyper-tension were also assessed. Pre-eclampsia was 
defined by ICD-9-CM codes 642.3x–642.6x listed anywhere on the discharge record, and 
pre-pregnancy hypertension by ICD-9-CM codes 642.0x, 642.2x, 642.7x, 401.0x, 401.1x, 
401.9x, 437.2x, or 402.xx–405.xx9 listed anywhere on the discharge record. Age was 
categorized as: 15–19, 20–24, 25–29, 30–34, 35–39, and 40–44 years. Cesarean section was 
identified by DRG codes 370 and 371 from January 2000 through September 2007 and 765 
and 766 from October 2007 through December 2010. Race/ethnicity was categorized as non-
Hispanic white, non-Hispanic black, Hispanic, and Asian/Pacific Islander in the 12 states 
reporting race/ethnicity. Seven states (Iowa, Kentucky, North Carolina, Oregon, Utah, 
Washington, and West Virginia) reported no information on either race or ethnicity for ≥3 
years during the study period. Race/ethnicity was the only variable in this analysis that was 
not consistently reported.
Statistical Methods
In 2014, age-standardized rates of PDM deliveries were estimated overall, by state, and by 
selected characteristics. The proportion of deliveries obtained from the 2000 HCUP National 
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Inpatient Sample for the age groups 15–19, 20–24, 25–29, 30–34, 35–39, and 40–44 years 
was used to standardize the distribution of deliveries by age across years. SAS software, 
version 9.3 and SUDAAN, version 11.0.0 were used for data management and analyses to 
produce estimates. Data were missing for California in 2002 and Hawaii in 2005. For these 
two states, all variables were imputed for the missing years using PROC MI in SAS. 
Imputation was based on data from other years and the number of deliveries was obtained by 
DRG codes from HCUPnet.10 Less than 1% of data were missing for other variables for the 
remaining states and years, but for consistency they were also imputed. However, among the 
12 states reporting race and ethnicity, race and ethnicity were missing, on average, 26.2% 
per year. The imputed overall age-standardized rates were compared with complete-case 
overall standardized PDM rates. Differences between the two methods were not more than 
0.01 percentage point in any year. General linear regression with a log-link and binomial 
distribution was used to assess the annual change in PDM prevalence over 11 years and to 
test for a statistically significant change in prevalence over time. This study was reviewed by 
the Human Subjects Coordinator at CDC and as an analysis of secondary data without 
identifiers, was determined not to require IRB review.
Results
Overall, the number of PDM deliveries increased from 13,217 in 2000 to 18,168 in 2010. 
The age-standardized prevalence of PDM increased from 0.65 per 100 deliveries in 2000 to 
0.89 per 100 deliveries in 2010, for a relative increase of 37% (Table 1). The greatest 
absolute increase occurred in Hawaii (from 0.66 to 1.15 per 100 deliveries) and the lowest 
increase, both absolute and relative, occurred in New Jersey (from 0.61 to 0.66 per 100 
deliveries). Five of the six states with the highest relative increase in PDM deliveries 
(≥69%) were in the Western region (Hawaii, Oregon, Arizona, Utah, and Washington), but 
the region with the overall highest relative increase in this study was the Midwest (61%) 
(Figure 1A and 1B). Throughout most years, the four states with the highest rates were in 
the South (South Carolina, North Carolina, Kentucky, and West Virginia).
PDM delivery rates in all 19 states increased significantly (p<0.01) across all age groups, 
but the greatest increases were among women aged 35–39 years, followed by those aged 15–
19 years (relative changes of 47% and 41%, respectively) (Table 2). Crude and age-
standardized PDM delivery rates per 100 births also increased significantly (p<0.01) among 
all racial/ethnic groups. Asians and Hispanics had higher crude relative increases (41% for 
Asian/Pacific Islanders, 39% for Hispanics, 33% for non-Hispanic blacks, and 31% for non-
Hispanic whites). The age-standardized relative increases were similar across races and 
ethnicities (range, 24%–29%). However, non-Hispanic blacks, followed by Hispanics, had 
the highest absolute change in age-standardized rates (0.26 and 0.20 per 100 deliveries, 
respectively), and throughout the time period, had the highest rates of PDM. The relative 
increase in PDM among the 12 states that had race data during the entire period was 28%, 
whereas the relative increase was 84% among the seven states that did not report race or 
ethnicity consistently throughout the study.
From 2000 to 2010, the proportion of PDM deliveries with pre-pregnancy hypertension 
increased from 7.4% to 14.1% (relative increase, 91%) (Figure 2). The proportion of PDM 
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deliveries with preeclampsia increased from 14.6% to 16.9% (relative increase, 16%) and 
the annual change was significant (p=0.05). The proportion of PDM deliveries with private 
insurance as the expected primary payer decreased significantly from 55.5% to 40% 
(relative change, −28%; annual change, p<0.001), whereas the proportion expected to be 
funded by Medicaid/Medicare increased from 39.9% to 54.9% (relative increase, 38%; 
annual change, p<0.001). The proportion of PDM cesarean section deliveries increased from 
50.9% in 2000 to 62.1% in 2010 (relative increase, 22%; annual change, p<0.001).
Discussion
This study indicates that PDM deliveries in 19 states are increasing across all demographic 
groups (e.g., age, race/ethnicity) and geographies (e.g., states, regions), thus, the increase in 
PDM is widespread in the 19 examined states. This is consistent with national trends of 
diabetes prevalence,1,11,12 including women aged ≥18 years.13 Numerous studies have 
found that elevated blood glucose levels in early pregnancy are associated with a 
significantly increased risk of pregnancy-related hypertension, birth defects, stillbirth, and 
preterm birth in infants of women with frank diabetes.14,15 However, the majority of women 
with PDM do not plan their pregnancies in advance and become pregnant with poor blood 
glucose control.16
The increase in PDM deliveries followed the emerging increase of diabetes in adolescents,17 
which paralleled the increase in overweight prevalence among youth from 1963 to 1994.18 
Not only are PDM deliveries becoming more common, but the proportion complicated by 
hypertension, whether pre-eclampsia or pre-pregnancy hypertension, has increased 
significantly. The 91% increase in pre-pregnancy hypertension among PDM deliveries is 
consistent with national data documenting a large growth in the prevalence of diabetes and 
hypertension comorbidity among adults aged 20–44 years in the 2000s.19 Further, the 
increase of hyper-tension in PDM deliveries poses a threat to their children because 
uncontrolled diabetes, untreated hypertension, and hypertension treatment are associated 
with congenital heart defects and other adverse health outcomes.3,19
It has long been established that diabetes disproportionately affects those with lower SES, 
particularly among women.20 Throughout the study period, the proportion of PDM 
deliveries expected to be funded by the Centers for Medicare and Medicaid Services 
increased significantly. Starting in 1991, all state Medicaid programs were required to cover 
pregnant women with incomes <133% of the federal poverty level.21 Notably, Medicaid 
funded over half of the PDM deliveries by 2010 in the 19 assessed states.
The increase in PDM rates among racial and ethnic minorities may be in part due to low 
SES and other unmeasured factors that increase PDM risk. The highest rate of PDM 
throughout the study period and the highest degree of absolute change in rate were observed 
among non-Hispanic blacks. This high prevalence is also consistent with higher rates of 
diabetes and obesity (a known risk factor for type 2 diabetes) among black women 
compared to Hispanic and white women.22,23 However, the highest crude rates of relative 
increase in PDM by race/ethnicity were among Hispanics and Asians; the highest age-
standardized rate of relative increase was among non-Hispanic white women. From 1999 to 
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2008, the prevalence of obesity increased more among Mexican-American women aged 20–
39 years (relative increase of 29%) than among non-Hispanic blacks (relative increase of 
2%), possibly explaining the greater increase among Hispanics. Non-Hispanic white women 
of the same age experienced a similar increase in obesity as Hispanic women (relative 
increase of 28%).22 Although studies have shown that the prevalence of obesity among 
Asian women is substantially lower than the national average, Asians are at risk for diabetes 
at lower levels of body mass.24
States with the highest rates of PDM by 2010 were mostly in the South, whereas states in the 
North had the lowest rates as well as some of the lowest rates of increase. In general, 
diabetes prevalence is highest in the Southeastern U.S.25 Regional differences in PDM 
trends may be related to demographic variation in race/ethnicity and SES. Southern states 
with some of the highest PDM rates have a greater proportion of African Americans than 
other regions, while western states with the highest relative rates of increase in PDM have 
the highest proportion of Hispanics. Hawaii has the largest proportion of Asians in this 
study, which may explain in part of the high rate and high increase in that state.
One limitation of this study is that data are not available for all 50 states, thus the results 
may not be representative of the entire nation or all regions. However, no data source that 
covers all states is readily available. A second limitation is the inconsistency in availability 
of race/ethnicity data across states. Also, no data on pre-pregnancy weight or BMI were 
available. Because the effect of obesity varies across age and race/ethnicity with respect to 
PDM,26 it was not possible to further examine the variability across race/ethnicity between 
crude and age-standardized rates. Another limitation is that the PDM rates for race and 
ethnicity do not represent the 19 states in the entire study population. Also, close to 26% of 
discharges were missing data on race and ethnicity and thus were imputed. The seven states 
that did not report race and ethnicity consistently during the study experienced much higher 
relative rates of increase than the states that did report race; the reason may be due, in part, 
to their having the lowest rates to begin with and therefore having the greatest increase when 
using a multiplicative measure like relative change. Moreover, racial and ethnic differences 
noted may well be due to other unmeasured factors. Although ICD-9 codes are not as 
reliable as a clinical diagnosis of diabetes, validation studies done with hospital discharges 
found sensitivity of 78.0%–95.3%, specificity of 99.4%–100.0%, and positive predictive 
value of 94.0%–97.6%.27 In addition, the ICD codes for type of diabetes (e.g., type 1 or 2) 
are not reliable, thus, it was not possible to study the conditions that underlie these trends. In 
addition, no data are available for the proportion of type 2 PDM in the U.S. However, in the 
1990s, the incidence of type 2 diabetes increased among youth aged 10–19 years who were 
obese and had a family history of type 2 diabetes.17 Finally, using ICD codes may under-
report complications such as hypertension in deliveries, with sensitivity as low as 58%.28 
This analysis found that <2% of all deliveries were affected by hypertension, but other 
studies reported that hypertension occurred in 5%–10% of pregnancies.29
This study found that increases in PDM were pervasive across demographic groups. 
Strikingly, this analysis found that PDM deliveries are also becoming more complicated as 
the proportion with hypertension, preeclampsia or pre-conception, is also increasing, a 
combination that places children born to women with diabetes at risk for serious adverse 
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outcomes. Meanwhile, publicly funded healthcare programs such as Medicare and Medicaid 
paid for an increasing number of PDM deliveries, while private insurance bore the cost of 
fewer, representing a shift in the financial burden of PDM. Finally, the rate of PDM is 
increasing among Hispanic women who represent a growing proportion of the population in 
which the risk of developing diabetes is also increasing. The increase in overweight 
prevalence is likely to be driving these increases. Effective diabetes prevention and control 
strategies for women of child-bearing age may help protect the health of women and their 
newborns.
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(A) Prevalence of pre-pregnancy diabetes per 100 deliveries among participating states, 
Healthcare Cost & Utilization Project State Inpatient Databases 2000. (B) Prevalence of pre-
pregnancy diabetes per 100 deliveries among participating states, Healthcare Cost & 
Utilization Project State Inpatient Databases 2010.
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Proportion of PDM deliveries with hypertension, 19 states 2000–2010.
PDM, pre-pregnancy type 1 or type 2 diabetes mellitus.
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